September 2026 Cannabis M&A: Curaleaf Bids $270M, Vireo Eyes 270 Doors

September 2026 cannabis M&A is defined by two stories: Curaleaf’s unsolicited $270 million cross-border bid for Aurora Cannabis, and Vireo Growth’s relentless acquisition campaign targeting roughly 270 dispensaries across Florida cannabis M&A activity, Nevada, and beyond. While the Curaleaf-Aurora battle plays out in Canadian securities filings and social media, Vireo closed its Nevada tuck-in and pressed forward on announced deals with FLUENT, C21, and Planet 13. Ohio contributed a quiet single-door acquisition. The rescheduling of state-licensed medical marijuana to Schedule III in April 2026 continues to reshape buyer strategy, with MSOs chasing DEA registration benefits and retooling capital allocation accordingly.

🔥 MARKET SIGNALS THIS MONTH:

• First hostile cross-border takeover bid in the cannabis sector since 2019, Curaleaf targets Aurora Cannabis at $270M; Aurora board unanimously rejects
• Vireo Growth on pace to surpass Trulieve (207 dispensaries) and Curaleaf (176 dispensaries) by dispensary count, multi-deal campaign across FL, NV, and CA accelerates
• Florida becomes a highly contested M&A market with three separate announced or pending transactions involving Vireo (FLUENT, C21, Planet 13 merger)

Florida: Announced Acquisition

Vireo Growth announced a definitive agreement to acquire FLUENT Corp. in an all-stock transaction, adding Florida retail doors to its rapidly expanding portfolio. The deal is part of an M&A campaign that, combined with the C21 and Planet 13 transactions, would position Vireo as a dominant force in Florida’s dispensary market.

🔥 Market Signal: Part of Vireo’s aggressive consolidation push across multiple states

Florida: Announced Acquisition

Vireo Growth announced the acquisition of C21 Florida operations, continuing its consolidation push in the state. Vireo Q2 2026 revenue jumped 335% year over year to $209 million, fueled by recently closed deals and signaling the company’s ability to integrate at scale.

🔥 Market Signal: Major revenue growth demonstrates successful integration capability

Florida: Announced Merger

Vireo Growth and Planet 13 Holdings announced a planned merger, combining Vireo’s expanding retail network with Planet 13’s vertically integrated Florida operations including a new extraction facility and a forthcoming Sarasota store. Planet 13 reported Q2 2026 Florida revenue up 17.1% quarter over quarter, making it a material addition to Vireo’s footprint.

🔥 Market Signal: Florida consolidation intensifies with third major Vireo transaction

Ohio: Closed Acquisition

Klutch Cannabis acquired the Grandview dispensary at 1305 Holly Ave., Columbus, from Culture Cannabis, with the Ohio cannabis market Division of Cannabis Control approving the transfer. The location marks Klutch’s second Columbus retail door, opened just weeks after its first, and the company is simultaneously relocating its Tallmadge store to a new flagship in Akron.

Status: Closed; single-door tuck-in acquisition

Nevada: Closed Acquisition

Vireo Growth closed its acquisition of M3 Wellness, a single dispensary in Hawthorne, Nevada, for $500,000 total consideration ($290,000 cash, $210,000 in 13,888 subordinate voting shares at $15.12 per share). The deal adds Nevada to Vireo’s growing state count and is part of the same Q2 M&A campaign that included Hawthorne, Eaze, and Bridgewell closes.

Status: Closed; $500,000 mixed cash and stock consideration

California: Closed Merger

Vireo Growth completed its merger with Eaze Inc., issuing 90,379,591 subordinate voting shares to execute the transaction and gain California distribution and delivery infrastructure. Combined with a separate joint venture with Glass House Brands for California dispensary operations, Vireo now has multi-channel exposure in one of the country’s largest cannabis markets.

Status: Closed; all-stock merger adding California delivery infrastructure

United States / Canada: Announced Hostile Bid

Curaleaf Holdings launched an unsolicited takeover bid for Canadian licensed producer Aurora Cannabis, offering US$4.00 per share (later capped at US$5.00), totaling approximately US$270 million. Aurora’s board unanimously rejected the offer on September 2, 2026, arguing it undervalued the company by 23% to 63% depending on the metric used; the bid remains open through at least December 1, 2026, and the proposed combination would create an entity operating in 17 countries with more than $1.5 billion in trailing revenue.

🔥 Market Signal: First hostile cross-border cannabis takeover bid since 2019

Multi-State: Closed Acquisition

Vireo Growth closed its acquisition of PharmaCann in a multi-state transaction, adding to the pipeline of deals that collectively position Vireo to reach approximately 270 dispensaries when all close. The PharmaCann acquisition spans multiple states and extends Vireo’s vertical integration alongside the FLUENT, C21, Schwazze, and Planet 13 transactions announced or closed during the same consolidation wave.

Status: Closed; multi-state acquisition strengthening vertical integration

Curaleaf’s hostile bid for Aurora Cannabis is the deal that changes the template.

This marks the first hostile M&A effort in the cannabis sector since 2019. Curaleaf’s pitch is vertical integration abroad: Aurora’s four EU-GMP-certified cultivation facilities (353,400 sq ft combined) and European medical revenue that grew at an 80% compound annual rate to C$131.8 million in fiscal 2026 would fill a gap Curaleaf cannot build quickly from its single small Portuguese site. Aurora sees it differently, pointing to Curaleaf’s multi-voting share structure that gives Chairman Boris Jordan 69% voting control on just 18% economic interest, a governance discount that Aurora shareholders would inherit at 3.2% of votes in the combined entity. The rejection does not end the bid. With the offer open through December 1, 2026, the Curaleaf-Aurora outcome will signal whether cross-border cannabis consolidation becomes a repeatable playbook or a cautionary case study for the next MSO eyeing foreign distribution assets.

Florida, the largest medical marijuana market in the country, is a consolidation battleground. Three separate Vireo transactions targeting FLUENT, C21, and Planet 13 in the same quarter signal that Florida’s medical marijuana market is pulling in significant capital this quarter. Sellers with Florida retail doors are in a strong negotiating position.

Equity-heavy deal structures are common among Vireo’s recent transactions. Vireo’s FLUENT acquisition is structured as an all-stock deal, its Eaze merger was funded primarily through share issuance, and its M3 Wellness purchase mixed cash and stock. Capital-constrained buyers are using equity to transact, which compresses seller liquidity at close but preserves cash for integration.

Schedule III rescheduling is functioning as a triage filter. Companies structured to claim 280E relief (Trulieve via DEA registration, Jushi via medical operations, Green Thumb on qualifying activities) are booking tax benefits from rescheduling. Those still pending DEA registration face a competitive disadvantage in deal pricing and integration capacity.

Vireo’s M&A pace has been rapid this year. Within a single calendar year, the company absorbed Schwazze (45 doors, CO/NM), Eaze (CA), Hawthorne (from Scotts Miracle-Gro), M3 Wellness (NV), and PharmaCann, and announced FLUENT, C21, Planet 13, and select Cannabist assets. Integration risk is substantial; rising revenue alongside falling margin would be the earliest warning sign.

Green Thumb’s $50M share repurchase program, renewed September 23, 2026 after more than $80M in buybacks this year, signals that some well-capitalized MSOs are betting on their own equity over external acquisitions, a contrast to Vireo’s external growth posture worth watching as valuation multiples shift.

Cannabis Acquisition Opportunities Available Nationwide

CannDev has compiled a portfolio of cannabis acquisition opportunities across multiple states, including operational dispensaries, licensed facilities, and turn-key locations ready for immediate deployment. These are CannDev’s own deals, licenses, and properties available for purchase or lease.

Gainesville, FL

Asking: $4,100,000

• Clean, fully awarded MMTC license with a turn-key starter facility ready for all three authorizations
• Flexible lease on an expandable 10 acre site with cultivation, processing, and dispensing infrastructure already in place, plus option to lease neighboring parcels with 12,000 sq ft indoor growing and 19,000 sq ft greenhouse space
• Includes approximately $750K in equipment, consumables, and prepaid vendor deposits
• Landlord will fund up to $5M for expansion, including CapEx and tenant improvements
• Seller financing available at 12.75% APR over up to 60 monthly payments, with seller open to holding a small continuing interest

Bergen County, NJ

Asking: $1,500,000

• 1,778 sq ft space within a 7,200 sq ft multi-tenant strip center
• 40 parking spaces
• 24 month entitlement period at $3,500 per month, then $9,779 per month post entitlement
• Open and operating, currently mismanaged

Peekskill, NY

Asking: $1,800,000 (recently reduced)

• $2.8M revenue over the last 12 months
• EBITDA over $200K, excluding owner salaries
• Sellers recently reduced price to move quickly

Queens, NY

Asking: $850,000

• Rare operational store opportunity under $1M
• $1.2M in revenue
• Double digit EBITDA

Brooklyn, NY

Asking: $3,000,000

• Open just over 12 months
• $2.6M gross revenue over the last 12 months with increasing revenues
• $850K net profit over the last 12 months
• $25,750 monthly rent on a 10+ year lease for a 2,000 sq ft space, 25K daily traffic count

Kingston, NY

Structure: Management agreement with path to ownership

• Operational store, owner seeking an operating partner to step in
• Partner runs day to day operations under a negotiated management agreement
• Structured with the intent for the partner to own the business at the end of the term
• Strong fit for someone looking to get into an operating store without a full upfront purchase

Off Market, NY

• Three additional off market stores available doing $6M+ in annual sales
• Located in Manhattan
• Full financials available directly with ownership under executed NDA

📬 Track Cannabis M&A Every Month

Get monthly cannabis M&A deal flow, valuation data, and market signals delivered to your inbox. Built for investors and executives evaluating acquisition timing.